Markets:

Overview

News

Currencies

International

Treasuries

Valneva SE - American Depositary Shares (NQ:VALN)

9.950 +0.270 (+2.79%)

Streaming Delayed Price Updated: 1:02 PM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Valneva SE - American Depositary Shares

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout ↗

March 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative...

Via Benzinga

76 Biggest Movers From Yesterday ↗

March 08, 2022

Gainers Houston American Energy Corp. (NYSE: HUSA) surged 494.7% to close at $11.30 on Monday amid continued momentum and an increase in the price of oil. Imperial Petroleum Inc...

Via Benzinga

Why Are Valneva Shares Rising Today Premarket? ↗

February 03, 2022

Valneva SE (NASDAQ: VALN) expects its COVID-19 vaccine candidate to boost its sales in FY22 considerably, after

Via Benzinga

46 Stocks Moving In Monday's Mid-Day Session ↗

March 07, 2022

Gainers Houston American Energy Corp. (NYSE: HUSA) jumped 137.4% to $4.5150 amid continued momentum and an increase in the price of oil. Imperial Petroleum Inc. (NASDAQ:...

Via Benzinga

42 Stocks Moving in Monday's Pre-Market Session ↗

March 07, 2022

Gainers Nine Energy Service, Inc. (NYSE: NINE) rose 96.7% to $3.54 in pre-market trading after climbing around 43% on Friday. Shares of low-priced energy stocks jumped as...

Via Benzinga

Valneva Kickstarts Phase 3 Trial Of Chikungunya Vaccine Candidate In Adolescents ↗

February 01, 2022

Valneva SE (NASDAQ: VALN) has

Via Benzinga

Why Valneva Shares Are Soaring Today ↗

January 19, 2022

Valneva SE (NASDAQ: VALN) is trading significantly higher Wednesday following results from an initial laboratory study, which demonstrated that serum antibodies induced by...

Via Benzinga

The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution ↗

March 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine...

Via Benzinga

The Daily Biotech Pulse: Lilly's Jardiance Gets Nod For Heart Failure, Pulmatrix Announces Reverse Split, Reata Awaits FDA Decision ↗

February 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Lilly's Co-developed Diabetes Drug Jardiance Gets Label Expansion To...

Via Benzinga

Valneva Secures £20M From Scottish Enterprise For Vaccine Development ↗

February 22, 2022

Valneva SE (NASDAQ: VALN) has been awarded research and development funding of up to £20 million by Scottish Enterprise. The investment from Scotland's...

Via Benzinga

Valneva - Pfizer Choose Three-Dose Schedule For Lyme Vaccine Candidate Moving Forward ↗

February 04, 2022

Valneva SE (NASDAQ: VALN) and Pfizer Inc (NYSE: PFE) have

Via Benzinga

The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures ↗

February 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation ↗

February 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 03, 2022

Good morning, trader! We're starting off another day of trading with a breakdown of the biggest pre-market stock movers for Thursday!

Via InvestorPlace

The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program ↗

February 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Valneva Advances Booster Phase Of Its Cov-Compare COVID-19 Vaccine Trial ↗

January 25, 2022

Valneva SE (NASDAQ: VALN) has started booster vaccinations in adult participants from its Phase 3 pivotal trial, Cov-Compare. This booster extension is...

Via Benzinga

48 Biggest Movers From Yesterday ↗

January 21, 2022

Gainers Aptorum Group Limited (NYSE: APM) shares jumped 38.5% to close at $1.69 on Thursday after the company announced it received FDA Orphan Drug designation for...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 20, 2022

Gainers Aptorum Group (NASDAQ:APM) stock increased by 32.8% to $1.62 during Thursday's regular session. Aptorum Group's stock is trading at a volume of 86.4...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

January 20, 2022

Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 29.8% to $0.2550. Baudax Bio, last month, announced a $4.2 million registered direct offering. Vertical Aerospace Ltd. (NYSE...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; American Airlines Posts Narrower-Than-Expected Loss ↗

January 20, 2022

Following the market opening Thursday, the Dow traded up 0.92% to 35,352.17 while the NASDAQ rose 1.61% to 14,570.49. The S&P also rose, gaining, 1.06% to 4,581.00. The U.S....

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 20, 2022

Gainers Baudax Bio (NASDAQ:BXRX) stock rose 32.2% to $0.26 during Thursday's pre-market session. The company's market cap stands at $21.9 million. Aptorum Group (...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

January 20, 2022

Good morning, trader! It's time to dive into another day of investing with the biggest pre-market stock movers for Thursday!

Via InvestorPlace

21 Stocks Moving in Thursday's Pre-Market Session ↗

January 20, 2022

Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 36.2% to $0.2675 in pre-market trading. Baudax Bio, last month, announced a $4.2 million registered direct offering. Marker...

Via Benzinga

52 Biggest Movers From Yesterday ↗

January 20, 2022

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion. G...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 19, 2022

Gainers Acorda Therapeutics (NASDAQ:ACOR)...

Via Benzinga

VALN Stock Alert: 4 Things to Know About the Vaccine News Sending Valneva Soaring ↗

January 19, 2022

Valneva is picking up attention as the biotech firm is up more than 30% today. Will its vaccine candidate power VALN stock to new highs?

Via InvestorPlace

Three doses of Valneva's COVID-19 Vaccine Neutralizes Omicron Variant, Lab Study Shows ↗

January 19, 2022

Valneva SE (NASDAQ: VALN) has announced results from an initial laboratory study demonstrating that serum antibodies induced by three doses of Valneva's COVID-19 vaccine...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 19, 2022

Gainers Zogenix (NASDAQ:ZGNX) stock rose 68.2% to $26.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.4 billion. Lucid...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 19, 2022

Good morning, investor! We're diving right into trading today with a look at the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales ↗

January 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Illumina Announces Co-Development Partnership With SomaScan For Accelerating...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.